Sign Petition

SORAFENIB for all primary Liver cancer sufferers

520 Signatures Goal: 1,000

As you may be aware there have been reports in the media of late of the decision made by the NICE (National Institute for Clinical Excellence) to block the funding and availability to the NHS of Sorafenib (Nexavar) as an effective life extending treatment for sufferers of primary Liver cancer. This treatment is beyond the financial means of the vast majority of sufferers. Andrew Dillon, chief executive of NICE, said: "The price being asked by [the manufacturer] Bayer is simply too high to justify using NHS money which could be spent on better value cancer treatments." [Source: www.bbc.co.uk/news] For those sufferers who have limited or no other options available regarding treatment, other than the short term use but painful ordeal of chemotherapy and distressing surgical procedures, they will, without this drug stand little or no chance at all of increasing and furthering their lives. This not only has an impact on the sufferer but causes great frustration for their families who have to stand by and watch the effects of this terrible disease when they know there is a way to improve and extend the lives of their loved ones. This is an appeal for you to join us to publicise this travesty of NHS funding by signing this online petition. It is our hope that with enough support the NICE and the pharmaceutical company would come together to help provide patients, not just across the rest of Europe - where this treatment is widely available and funded â

Comment

520

Signatures

  • 4 months ago
    Liz Whomsley United Kingdom
    4 months ago
  • 6 years ago
    Scott Gillespie United Kingdom
    6 years ago
  • 6 years ago
    Audrey Castleton United Kingdom
    6 years ago
  • 6 years ago
    lyn donovan United Kingdom
    6 years ago
  • 6 years ago
    Chris Fearn United Kingdom
    6 years ago
  • 6 years ago
    Pauline Fairley United Kingdom
    6 years ago
  • 6 years ago
    Janice Morris United Kingdom
    6 years ago
  • 6 years ago
    john walker United Kingdom
    6 years ago
  • 6 years ago
    bev richards United Kingdom
    6 years ago
  • 6 years ago
    Trudy Kitabayashi United Kingdom
    6 years ago
  • 6 years ago
    Yasuki Kitabayashi United Kingdom
    6 years ago
  • 6 years ago
    Trudy Kitabayashi United Kingdom
    6 years ago
  • 6 years ago
    juliana kemball-williams United Kingdom
    6 years ago
  • 6 years ago
    Karen Jones United Kingdom
    6 years ago
  • 6 years ago
    Andy Warner United Kingdom
    6 years ago
See More